Enhertu granted FDA Breakthrough Therapy Designation
April 27, 2022Research and Development
AstraZeneca’s Enhertu® (fam-trastuzumab deruxtecan-nxki) has been granted breakthrough therapy designation in the US for adult patients with HER2-low metastatic breast …
Beijing enforces mass COVID-19 testing and closes neighbourhoods
April 26, 2022Medical Communications
Beijing is enforcing mass testing and closing down access to neighbourhoods as it seeks to contain a new COVID-19 outbreak. …
UK study finds raising frequency of COPD flare ups increases risk of death
April 26, 2022Manufacturing and Production
The EXACOS UK study in Chronic Obstructive Pulmonary Disease (COPD), funded by AstraZeneca, has shown that an increasing frequency of …
FDA approves first COVID-19 treatment for young children
April 26, 2022Manufacturing and Production
The FDA has expanded the approval of the COVID-19 treatment, Veklury (remdesivir), to include pediatric patients 28 days of age …
Mundipharma and Cidara Therapeutics report positive Phase III results into candidemia treatment
April 26, 2022Medical Communications
Mundipharma and Cidara Therapeutics have presented data from the Phase III ReSTORE trial of rezafungin, in the treatment of candidemia …
New data for Shionogi’s COVID-19 antiviral show rapid virus clearance
April 25, 2022Sales and Marketing
Shionogi has announced new results from two late-breaking presentations of S-217622. This is an investigational 3CL protease inhibitor that was …
National shortage of HRT medication due to high demand
April 25, 2022Sales and Marketing
The national shortage of HRT products could have an impact on some women, who may not be able to sleep …
EMA recommend new treatment option for severe postpartum haemorrhage
April 25, 2022Sales and Marketing
Novo Nordisk has announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion …
Ukraine: crisis for people with chronic diseases
April 25, 2022Sales and Marketing
Preliminary results from an ongoing nationwide health needs assessment, conducted by WHO in partnership with Premise, indicate that one in …
Vivesto signs agreement with CRO to evaluate anti-cancer drug formulations
April 22, 2022Medical Communications
Vivesto AB, an oncology-focused pharmaceutical company, has announced that it is advancing research into its proprietary drug delivery formulations, and …
Orasis Pharmaceuticals announces positive Phase III results of eye drop candidate
April 22, 2022Medical Communications
Orasis Pharmaceuticals has announced that the Phase III NEAR-1 and NEAR-2 clinical trials, which evaluated the efficacy and safety of …
FDA approves Phase III Acute Respiratory Distress Syndrome (ARDS) Trial
April 22, 2022Medical Communications
The FDA has approved Direct Biologics to proceed with its Phase III clinical trial into the treatment of Acute Respiratory …
WHO “strongly recommends” Paxlovid, calls for wide distribution from Pfizer
April 22, 2022Medical Communications
WHO has endorsed the use of Pfizer’s oral antiviral treatment for high-risk patients with mild COVID-19, following an analysis of …
NIHR-supported trial reveals vaccine boosters maintain immunity three months on
April 21, 2022Business Services
Latest results form the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses …
FDA’s Cancer Advisory Committee to evaluate safety of P13K inhibitors
April 21, 2022Business Services
The FDA’s Oncologic Drugs Advisory Committee is holding a meeting today to discuss safety findings across the entire class of …
PacBio and Children’s Mercy Kansas City expand collaboration in rare disease
April 21, 2022Business Services
PacBio has announced an expanded research collaboration with Children’s Mercy Kansas City, to use the multi-omics capabilities of PacBio’s Sequel …
New Programme to tackle health disparities and inequalities for women with heart failure
April 21, 2022Business Services
Women diagnosed with heart failure have worse outcomes compared to men, in spite of a similar prevalence of the chronic …
Takeda Nuvaxovid COVID-19 vaccine approved in Japan
April 20, 2022Research and Development
Takeda’s Nuvaxovid Intramuscular Injection (Nuvaxovid) has been approved by the Japan Mnistry of Health, Labour and Welfare (MHLW). This is …
Care to Collaborate: Cydar Medical announces partnership with Medtronic
April 20, 2022Research and Development
Cydar Medical has announced a strategic collaboration with leading healthcare technology company Medtronic. Under the pilot arrangement, Cydar’s EV Maps …
Study initiated for first miniaturised robotic-assisted surgery platform
April 20, 2022Research and Development
Virtual Incision Corporation has announced the FDA approval of an Investigational Device Exemption (IDE) supplement to complete the final stage …
